Human SNCA adenoviral particles

The SNCA gene, also known as the α-synuclein gene, plays a key role in the pathogenesis of neurodegenerative diseases, especially Parkinson's disease (PD) and other synucleinopathies. The gene encodes α-synuclein, a presynaptic neuronal protein involved in synaptic vesicle trafficking and neurotransmitter release. Under pathological conditions, α-synuclein aggregates to form insoluble fibrils, Lewy bodies - a hallmark of Parkinson's disease. Studying the SNCA gene is essential for understanding the molecular mechanisms of neurodegenerative diseases and developing therapeutic strategies targeting α-synuclein aggregation.

Human SNCA adenoviral particles are recombinant viral vectors designed to deliver the human SNCA gene to target cells or tissues, allowing researchers to study its function and its dysregulation in disease models. Adenoviral vectors are widely used due to their high transduction efficiency, ability to infect both dividing and non-dividing cells, and ability to carry large gene inserts. These vectors are replication-defective, ensuring biosafety while enabling stable and sustained transgene expression. Human SNCA adenoviral vectors are particularly valuable in preclinical studies, as they can promote overexpression of α-synuclein in cultured neurons, animal models, or organoids to mimic Parkinson's disease-like pathology.